That the agency is considering revamping its advisory-committee procedures is a "huge deal", given that much of the world looks to the FDA for its scientific analyses, says Reshma Ramachandran...
At the listening session, Califf said that "one of the most difficult areas that we need to address" is how to have a disagreement as a scientific community "without undermining the public's confidence and trust in science".
Pointing to some of the high-profile cases in which the FDA has overridden the consensus of its advisers, Peter Lurie, president of the Center for Science in the Public Interest in Washington DC, tells Nature that it's "hard to escape the suspicion" that any move to get rid of voting isn't just "rooted in a desire to avoid controversies".
Collection
[
|
...
]